Tag

immunovia

Jeff Borcherding

Immunovia Inc achieves Clinical Laboratory Licensure

May 18, 2022

The Rhode Island Department of …

In a new job

Immunovia appoints Head of Market Access US

May 16, 2022

The company has appointed Natalie …

Jeff Borcherding

Immunovia appoints CEO of its US subsidiary

March 30, 2022

Immunovia has appointed Jeff Borcherding …

Patrik Dahlen

Immunovia’s CEO to step down

December 1, 2021

Immunovia has announced that the …

Thomas King

Immunovia receives Presidential Poster Award

October 29, 2021

Immunovia has announced that Thomas …

Patrik Dahlen

Immunovia enters licensing agreement with JW BioScience

September 14, 2021

Immunovia has strengthened its patent …

Immunovia lab

Immunovia Inc to begin patient testing in the US

August 4, 2021

Immunovia, Inc has received final …

On the threshold of commercial launch

April 28, 2021

Originating from research at Lund …

Patrik Dahlen

“This is a historical moment for Immunovia”

March 30, 2021

Immunovia has announced improved performance …

Mats Grahn

Q&A: Mats Grahn, CEO of Immunovia

January 1, 2020

Immunovia has achieved a major …

Mats Grahn

Immunovia collaborates with Lund University

September 11, 2017

Immunovia announces a collaboration with …

boston

Immunovia establishes US headquarters

June 29, 2017

The company has chosen Boston, …

immunovia

Immunovia’s retrospective autoimmune disease study has been finalized

March 8, 2017

Immunovia announces that the large …

immunovia

Data from Immunovia’s new study announced

January 16, 2017

Immunovia has announced that the …

immunovia

Immunovia awarded 2016 Stars of Innovation Prize

November 29, 2016

The Swedish diagnostics company Immunovia …

immunovia

Immunovia announces successful completion of preferential rights issue

October 20, 2016

Immunovia has successfully completed its …

1
2